114
Participants
Start Date
July 31, 2014
Primary Completion Date
February 26, 2021
Study Completion Date
February 26, 2021
131I-MIBG
Vincristine
Irinotecan
Vorinostat
University of North Carolina, Chapel Hill
AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus, Atlanta
C.S Mott Children's Hospital, Ann Arbor
University of Chicago, Comer Children's Hospital, Chicago
Cook Children's Healthcare System, Fort Worth
Children Hospital of Colorado, Aurora
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Lucile Salter Packer Children's Hospital, Palo Alto
Seattle Children's Hospital, Seattle
Childrens Hospital Los Angeles, Los Angeles
Children's Hospital Boston, Boston
Cincinnati Children's Hospital Medical Center, Cincinnati
Children's Hospital of Philadelphia, Philadelphia
Hospital for Sick Children, Toronto
New Approaches to Neuroblastoma Therapy Consortium
OTHER